# First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors

> **NCT01469052** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 36 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** AG-013736
- **DRUG:** AG-013736
- **DRUG:** AG-013736
- **DRUG:** AG-013736
- **DRUG:** AG-013736
- **DRUG:** AG-013736

## Key facts

- **NCT ID:** NCT01469052
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2004-07
- **Final completion:** 2004-08
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2012-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01469052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01469052, "First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01469052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*